We recently demonstrated by using an ex vivo adhesion assay that Candida albicans yeast cells exhibit a unique binding affinity for the marginal zone of the spleen. This binding event provides a working model for studying mechanisms of organ dissemination of the fungus from the blood. By using the ex vivo assays reported here, we showed by bright-field and electron microscopic techniques that mouse spleen marginal zone cells capable of ingesting India ink particles are also involved in yeast cell attachment. During splenic clearance of yeast cells from the circulation in vivo, C. albicans is also associated exclusively with marginal zone cells capable of ingesting India ink. The ability to ingest the ink particles is not necessarily related to yeast cell adherence, because the fungal cells did not bind to phagocytic cells in the splenic red pulp. In fact, the marginal zone phagocytic cells appear to have a unique binding system, because yeast cells also did not bind to phagocytes in other tissues, such as the thymus and peritoneum, or to seven different myeloid cell lines. In addition, antibodies to a number of well-characterized murine adhesion molecules, such as leukocyte integrins, LECAM-1, and CD44, had no effect on binding. On the basis of these results, we propose that splenic marginal zone phagocytes express a novel adhesion system that involves either a unique adhesion molecule or previously described adhesion molecules with unique binding activities.
Infectious disease organisms usually target specific host tissues rather than invading organs randomly. The identification of host ligands and parasite adhesion molecules involved in the tissue specificity of infectious agents will explain mechanisms by which these agents disseminate within the host and may lead to innovative diagnostic and therapeutic approaches against deep-seated infectious diseases.
Candida albicans is the most common cause of opportunistic fungal diseases and is one of the leading infectious disease agents overall as a cause of nosocomial infections (6) . In immunocompromised patients, disseminated candidiasis is a serious disease, yet existing methods of diagnosing disseminated disease are inadequate, and treatments are often toxic for the patient. Of critical importance is understanding how C. albicans targets host organs following candidemia.
Over the past few years, four categories of adhesion molecules of C. albicans have been defined (2, 4) : protein moieties on C. albicans that react with host cell surface proteins; lectinlike protein molecules on C. albicans that react with sugar residues of host cell surface glycoproteins; carbohydrate moieties on C. albicans that react with unidentified host cell surface molecules; and unidentified surface molecules of C. albicans that are responsible for hydrophobic interactions with host cells. Despite the array of adhesins identified, the specificity of C. albicans for particular host organs and tissues remains undefined.
Recently, we adapted an ex vivo adherence assay to study the mechanisms of C. albicans dissemination from the blood to internal organs (5) . This same method was originally used to define lymphocyte homing receptors and mechanisms by * Corresponding author. which inflammatory cells accumulate at sites of tissue injury (1, 14, 19) . Our investigations revealed the remarkable adherence specificity of C. albicans yeast cells for tissue within the marginal zone of the spleen and the trabecular sinus of lymph nodes rich in tissue macrophages. Furthermore, the ex vivo assay was found to accurately reflect tissue binding sites of C. albicans during dissemination of the fungus from the circulation to the spleen, lymph nodes, and other tissues (5) .
The splenic binding pattern was especially intriguing because it provided a working model for defining a tissuespecific interaction between C. albicans and host tissue. The spleen is also an important organ for consideration because it participates in the vascular clearance of foreign particles, it actively takes up C. albicans from the circulation in experimental animals, and splenic lesions due to C. albicans are being recognized with increasing frequency and are associated with certain types of immune system defects (20) . The yeast binding specificity in the spleen may serve as a model for understanding the mechanisms of dissemination of C. albicans from the blood and may lead to the identification of a new adhesion ligand specific for the splenic marginal zone.
Here we determined whether the tissue-specific adhesion of C. albicans to the marginal zone of the spleen involves a host cell type specific for the marginal zone.
MATERUILS AND METHODS
Organisms and culture conditions. C. albicans A9, described previously (12, 21) ,um thick at -20°C (Frigocut 2800 N cryostat; Reichert-Jung, Leica, Inc., Deerfield, Ill.) and mounted onto Gold Seal Rite-On Micro Slides (Becton-Dickinson Labware, Lincoln Park, N.J.). The sections were air dried as described reviously (16) , and 100 ,ul of a yeast cell suspension (2 x 10 cells per ml) in Dulbecco modified Eagle medium (Sigma Chemical Co., St. Louis, Mo.) containing 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) (GIBCO, Grand Island, N.Y.) and 5% fetal bovine serum (Sigma) and adjusted to pH 7.4 with 1 N NaOH was added to the sections and incubated without rotation for 15 min at 5 to 8°C. The sections were fixed, stained with either crystal violet (16) or periodic acid-Schiffs reagent and hematoxylin (PASH) (5), and mounted in Permount, and cells were counted manually as described previously (16) .
In some experiments, antibody blocking studies were done to examine the potential role of known host adhesion molecules in the binding of C. albicans to the splenic marginal zone. Monoclonal antibodies specific for mouse leukocyte integrins LFA-1 (FD445.1 [17] ), Mac-1 (M1/70 [18] and SK431 [13a]), and VLA4 (R1/2 [13] ), L-selectin (previ- ously called LECAM-1 or homing receptor) (MEL-14 [9] ), and CD44 (MJ64 and IM7 [22] ) were tested. All of the antibodies were of rat origin and were partially purified by ammonium sulfate precipitation. C. albicans yeast cells (2 x 108/ml) were treated with 50 ,ug of each antibody per ml in Dulbecco modified Eagle medium plus 5% fetal bovine serum and 10 mM HEPES for 20 min on ice prior to the adhesion assay. After the incubation period, the yeast cells were used directly in the binding assay, which was done as described above. In other experiments, the spleen sections were also treated with monoclonal antibodies for 20 min prior to the addition of antibody-treated yeast cells.
In For ex vivo adherence, spleens were removed from animals injected i.v. with India ink as described above, rapidly frozen in Tissue Tek O.C.T. compound, and cryosectioned at a thickness of 16 ,um. The sections were collected on glass coverslips for ex vivo adherence as described above. Following yeast cell adherence, the sections were fixed in 3% glutaraldehyde for 2 h at 5 to 8°C, washed three times in PBS, postfixed in 2% OS04 for 2 h, and dehydrated in an ethanol series and then in acetone. Epon resin was added to the surface of each coverslip, and the sample was polymerized as described above. The coverslip was dissolved by treatment with hydrofluoric acid for 30 min at 22 to 25°C.
The flat Epon blocks were oriented in a new Epon block to allow thin sections to be made at a right angle with respect to the tissue section. Thin sections were collected on copper mesh grids, stained with uranyl acetate and Reynolds' lead citrate, and viewed on a Zeiss EMlOC/CA TEM at 65 kV.
RESULTS
Splenic cell type associated with ex vivo binding. At the lightmicroscopic level, the ex vivo adherence assay revealed a striking specificity of the stationary-phase hydrophilic yeast cells for the marginal zone areas of the spleen (Fig. 1A and  B) . Under the SEM, the association of C. albicans with the marginal zone was located at low power (Fig. 1C) . At a higher magnification, evidence was found for two types of binding: tenacious (Fig. 1D) and tenuous (Fig. 1E ). These observations suggested that the yeast cells interacted with the host cells, rather than intercellular material, such as extracellular matrix proteins, within the marginal zone.
To show more convincingly a cell-cell interaction, we did as before, but we oriented the sections in Epon resin to allow cutting of ultrathin cross-sections of the yeast-spleen interaction. The results of these studies clearly showed C. albicans attached to cells within the marginal zone. Furthermore, a correlation was noted between marginal zone cells that ingested India ink particles and host cells to which C. albicans yeast cells attached ( Fig. 2C and D) .
Splenic cell type associated with in vivo binding. Mice injected with India ink i.v. were given yeast cells i.v. and sacrificed as described in Materials and Methods. The spleens were removed from the animals and either cryosectioned, mounted on glass slides and stained with PASH for light microscopy or cut into small pieces with a razor blade, fixed in glutaraldehyde, and prepared for TEM. Viewed under bright-field microscopy, C albicans was found associated with cells that had ingested India ink. At low power, India ink was ingested, as noted above, by phagocytes associated with the marginal zone and red pulp of the spleen, but yeast cells were found only in the marginal zone (Fig.  3A) . At a higher magnification, yeast cells were found within vacuoles, indicating that they had been ingested by cells within the marginal zone. Furthermore, the same cells that ingested the India ink also ingested the C albicans yeast cells (Fig. 3B to D) .
By TEM, yeast cells were also found associated with marginal zone cells that were capable of ingesting India ink, but not with lymphocytic cells of the white pulp, which were devoid of India ink (Fig. 3E) Fig. 1D and E) . These two types of interactions correlated with the observation under bright-field microscopy that some yeast cells appear to be rigidly fixed to splenic tissue, while others tend to waver when the slides are moved.
We previously determined that during experimental candidemia in mice, yeast cells from the circulation become attached to the splenic marginal zone in a pattern identical to that observed in the ex vivo assay (5 Since phagocytes appeared to be the cell population which supported C. albicans adhesion in the splenic marginal zone, we examined further whether binding might be unique to these cells. The ex vivo assay demonstrated that mononuclear phagocytes in the thymus, splenic red pulp, and lymph node paracortex did not bind C. albicans (5; this study). We further examined cells isolated from uninflamed peritoneum and peritoneum inflamed for 3 days with thioglycolate (sources rich in resident and inflammatory macrophages, respectively), bone marrow neutrophils (14) , and six different myeloid cell lines (WEHI3, WEHI78/24, WEH1274, WEH1265, J774.1, and RAW264) for C. albicans adhesion under the conditions of the ex vivo assay at 4°C with no opsonization. None of these cell populations supported binding (data not shown).
Others have demonstrated that C. albicans produces integrinlike molecules that bind extracellular matrix proteins and the iC3b complement fragment (7, 8, 10, 15) . However, it is unlikely that these molecules are involved in the adherence described here because the yeast cells do not adhere to thymus tissue (5) or to multiple sites within the spleen. Furthermore, the adherence appears to involve yeast cells and specialized phagocytic cells.
The marginal zone is believed to be the site of entry of lymphocytes into the spleen (3, 11) ; therefore, we tested whether the adhesive event between C. albicans and the splenic marginal zone involved known adhesion pathways in mice. This was done by examining the effects of monoclonal antibodies to a variety of known murine adhesion proteins. MEL-14) . The antibodies were used to treat both the yeast cells and the tissue section in the ex vivo assay, but these antibodies had no effect on the binding of C. albicans yeast cells in the marginal zone.
Our studies indicate that the marginal zone of the spleen contains a unique adhesion system and is involved in the clearance of C. albicans from the circulation during fungemia. We propose that splenic marginal zone phagocytes express either a unique adhesion molecule or previously described adhesion molecules with unique binding activities. The adhesion system which binds C. albicans yeast cells potentially could be used by other cells, such as host lymphocytes, to gain entry into the spleen.
